Botanix kills superbug in a world-first study

Matt Callahan is the founder of Botanix Pharmaceuticals (ASX:BOT; OTC:BXPHF). He is the largest shareholder owning 7% of the company and early executive Bill Bosch owns 1.64%. This is important because Founder-led companies outperform the rest (via a S&P 500 study). Matt founded and sold iCeutica for US$60m in 2011. The team currently has world-class...

Categories Research